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ABSTRACT This paper identifies a common nutri-
tional pathway relating maternal through to fetal pro-
tein-energy malnutrition (PEM) and compromised fetal
kidney development. Thirty-one twin-bearing sheep
were fed either a control (n15) or low-protein diet
(n16, 17 vs. 8.7 g crude protein/MJ metabolizable
energy) from d 0 to 65 gestation (term, 145 d).
Effects on the maternal and fetal nutritional environ-
ment were characterized by sampling blood and amni-
otic fluid. Kidney development was characterized by
histology, immunohistochemistry, vascular corrosion
casts, and molecular biology. PEM had little measure-
able effect on maternal and fetal macronutrient bal-
ance (glucose, total protein, total amino acids, and
lactate were unaffected) or on fetal growth. PEM
decreased maternal and fetal urea concentration, which
blunted fetal ornithine availability and affected fetal
hepatic polyamine production. For the first time in a
large animal model, we associated these nutritional
effects with reduced micro- but not macrovascular
development in the fetal kidney. Maternal PEM specif-
ically impacts the fetal ornithine cycle, affecting cellu-
lar polyamine metabolism and microvascular develop-
ment of the fetal kidney, effects that likely underpin
programming of kidney development and function by a
maternal low protein diet.—Dunford, L. J., Sinclair,
K. D., Kwong, W. Y., Sturrock, C., Clifford, B. L., Giles,
T. C., Gardner, D. S.. Maternal protein-energy malnu-
trition during early pregnancy in sheep impacts the
fetal ornithine cycle to reduce fetal kidney micro-
vascular development. FASEB J. 28, 4880–4892 (2014).
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The World Health Organization estimates that 1.1
million children in the United States (0.8% of sampled
population) suffer from protein-energy malnutrition
(PEM; ref. 1). Globally, PEM is prevalent (8% inci-
dence), contributing toward the estimated 32 million
babies born small for gestational age each year, which
significantly increases rates of childhood mortality (2).
Humans evolved eating a seasonal diet high in plant-
based foodstuffs (fruits, vegetables, seeds, and nuts)
supplemented with lean, animal-derived protein (3).
Such a diet has a relatively high protein-energy density
and was replete with essential micronutrients, vitamins,
and minerals. While the rates of overweight and obesity
testify to the quantity of nutrition not being limiting in
the majority of Western countries, often the nutritional
quality remains poor, with malnutrition (e.g., PEM)
coexisting with obesity in many countries and even
within families (2, 4, 5). Malnutrition during pregnancy
has negative outcomes that extend beyond the progeny
(6–9); more recently, this hypothesis has become
known as the “developmental origins of health and
disease” and was a paradigm shift in our understanding of
the relationship between nutrition and reproductive biol-
ogy (10–14). Animal models have since filled the knowl-
edge gap between maternal diet and adult disease with
some mechanistic detail (15, 16). However, while there is
a plethora of information for expectant mothers on what
should constitute an appropriate maternal diet (e.g., in
the United Kingdom; http://www.nhs.uk/start4life),
and much is known about fetal nutrition, endocrinol-
ogy, and growth per se (17–19), a mechanistic pathway
from maternal malnutrition, potentially through fetal
malnutrition, to a specified disease outcome has not
been elucidated.
Low maternal intake of protein is associated with
intrauterine growth-restricted infants that become sus-
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ceptible to chronic kidney and/or cardiovascular dis-
ease (20–22). With this in mind, we developed a large
animal model of maternal PEM using sheep (23). The
sheep is particularly suitable for such an experiment,
having a long history of use for fetal physiological and
developmental research (24) and nutritional require-
ments that are well characterized (7, 25). A nutrition-
ally unbalanced maternal diet, with a decreased pro-
tein:energy ratio as opposed to a balanced reduction in
energy availability, has greater significance for early
fetal development because maternal metabolism is re-
quired to adjust substrate cycles to accommodate the
lack of amino acids rather than simply “buffer” an
energy deficit. The embryo (26) and subsequently the
fetus (18) have specific requirements for particular
patterns of substrate (glucose, amino acids, lactate) to
enable optimal growth, which exponentially decline as
gestation proceeds (27, 28). A high relative rate of
growth (i.e., during the embryonic rather than fetal
period) therefore demands a highly specific pattern of
substrate (particularly of amino acids) and metabolic
intermediates for ordered development of cells, tissues,
and organs. Thus, the quality of fetal nutrition is most
important early in gestation.
A number of studies using differing animal models
have shown that maternal protein or energy malnutri-
tion can affect the quantity (i.e., global reduction in
fetal amino acid availability) and/or quality (i.e., no
change in total concentration but reduction in avail-
ability of specific amino acids) of the fetal nutritional
milieu (29–33). On occasion, no effect (i.e., no reduc-
tion in total or individual concentrations of amino acids
in fetal plasma) has been reported (31, 34). This is
likely due to differences in experimental design, the
animal model, degree of maternal undernutrition, tim-
ing of sampling (cf. gestational age), and methodolog-
ical techniques. With respect to the kidney, maternal
PEM has been consistently shown to detrimentally
affect fetal kidney development and later function,
especially if instigated during the period of meta-
nephrogenesis in various species (for reviews, see refs.
35, 36). In nonhuman primates, global undernutrition
alters the fetal kidney transcriptome (37, 38), but no
renal phenotype in the resultant adults has yet been
described in this model. Hence, to our knowledge, no
study has related maternal PEM to a pattern of nutri-
ents in the fetal compartment that may account, in
part, for physiological programming of fetal kidney de-
velopment and function in later life. In this study, we were
interested in how maternal PEM may influence nutrient
patterns in the fetal compartment, but we were specifically
interested in effects on the fetal ornithine cycle: PEM is
likely to reduce maternal plasma urea through reduced
protein turnover, the molar mass of urea (60 g/mol) is
such that it easily crosses the placental barrier, and the
urea/ornithine cycle delivers considerable substrate for
polyamine synthesis, an important precursor of cell
proliferation. Furthermore, investigation of prenatal
factors that can negatively affect kidney development is
of particular merit: the mammalian kidney has ac-
quired its full complement of nephrons at, or shortly
after, birth (39, 40), a limited capacity for repair after
injury (41), and no clearly defined stem cell niche to
replace lost functional units such as glomeruli (42).
Hence, the kidney, much like the ovary, accommodates by
having a large reserve functional capacity (i.e.,70% loss
of nephrons before clinical symptoms present) which
buffers the inevitable and gradual loss of functional units
with time. For the kidney, like the ovary, any residual
deficit from birth represents a lifetime loss and may
precipitate an exacerbated, age-related functional de-
cline.
We have previously characterized an anatomically
and physiologically compromised kidney in adult sheep
that experienced maternal PEM during early gestation
coupled with a superimposed obesogenic environment
as adults (23). Here we have extended this model to
consider the effects that maternal PEM has on the
nutritional status of the mother and her fetus. In doing
so, we were able to identify an altered pattern of
nutrients that associates with compromised fetal kidney
microvascular development. In addition, with sufficient
numbers of male and female fetuses assigned to treat-
ment groups, we were able to consider potential sex-
specific interactions with maternal diet; an important
consideration for scientific studies (43) and one that
appears to underpin developmental origins of health
and disease, regardless of the model organism (44).
MATERIALS AND METHODS
Ethical approval
All procedures were performed in accordance with the UK
Animals (Scientific Procedures) Act, 1986 (Amended Regu-
lations 2013), and were approved by the Animal Welfare and
Ethical Review Board of the University of Nottingham. In
determining sample size for the study, we considered varia-
tion in fetal amino acid concentrations to be the main
outcome of interest. With respect to plasma ornithine, the
study had 80% power (, set at 0.05) to detect a 160 M
difference in the fetal plasma concentration of ornithine,
analyzed in a split-plot design with maternal diet as the whole
plot (variance, 26,310) and fetal sex as the subplot (variance,
27,504) and with n  15 replicates/group.
Animals and experimental design
Thirty-one pregnant Scottish Blackface ewes carrying twins
were randomly allocated to groups fed either a control
protein (CP) diet (n15) providing adequate protein from d
0 to 65 gestation (term 147 d), or a protein-restricted
low-protein (LP) diet from d 0 to 65 gestation (n16). On an
as-fed basis, the diets were isocaloric, with the effective level of
protein restriction being 8.7 vs. 17 g crude protein/MJ
metabolizable energy. These levels are in line with allowances
recommended by the UK Agricultural Research Council (45)
and the Agricultural and Food Research Council (46). Ewes
were fed the concentrate ration as 2 even meals at 9:00 AM
and 4:00 PM, with 100 g hay offered in the morning only to
maintain rumen function. Ewes were weighed and body
condition was scored [arbitrary units, 1 (emaciated) to 5
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(obese) scale; ref. 47 to crudely assess their response to the
diets. Blood samples were withdrawn by venepuncture prior
to mating (baseline, nonpregnant) and subsequently at d 28
and 65 of pregnancy. Blood was withdrawn into K-EDTA
tubes and centrifuged at 3000 rpm (800 g) for 10 min; the
resulting plasma was taken and stored at 20°C until further
analysis. Ewes received their last feed at 4:00 PM on d 64 of
gestation. At 9:00 AM on d 65 of gestation, the sheep were
euthanized by barbiturate overdose (Dolethal; 150 mg/kg;
Vetoquinol, Buckingham, UK), and the intact uteroplacental
unit with twin fetuses was retrieved. In 1 min after eutha-
nasia, amniotic fluid was sampled (10 ml) from each fetus and
stored at 20°C. Subsequently, a fetal blood sample (5 ml)
was withdrawn from an umbilical artery of each twin fetus and
handled and stored as described above. One twin from each
pair was semirandomly assigned (to balance the distribution
of sex within treatment group) to undergo a vascular corro-
sion cast procedure (control, n6 males and n8 females;
low protein, n8 males and n7 females) or a tissue collec-
tion procedure (control, n8 males and n8 females; low
protein, n9 males and n8 females) in which selected
tissues were either snap frozen in liquid nitrogen (e.g., the
right kidney) and stored at 80°C or fixed in 4% w/v
paraformaldehyde (18–24 h at 4°C), rinsed in 0.02 M PBS for
24 h, and finally transferred and stored long term in 70%
ethanol at room temperature. Due to occasional experimen-
tal difficulties, not all measurements were possible on all
samples; hence the appropriate experimental n for compari-
son is indicated in individual figures and tables.
Vascular corrosion casts
One fetus from each ewe was corrosion cast using 7 ml of
resin from Batson’s No. 17 Plastic Replica and Corrosion Kit
(Polysciences, Inc., Warrington, PA, USA), injected via the
umbilical artery in a retrograde direction in accordance with
the manufacturer’s protocol. After perfusion, the resin-cast
whole fetus was allowed to set on ice for 2–3 h, followed by
immersion in maceration solution (20% potassium hydrox-
ide) for 12–18 h at 50°C to remove the surrounding soft
tissue. Thereafter, the vascular cast was rinsed, dried, and
stored at room temperature. The surface area and volume of
the resin casts of each fetal kidney were quantified using a
Nanotom high-resolution computed tomography scanner
(GE Sensing and Inspection Technologies, Wunstorf, Ger-
many). X-ray slices were taken every 40 m throughout the
cast, averaging 2000 slices/fetus. Using Nanotom software,
these images were stacked and reconstructed in 3D (see
Supplemental Movie S1) to provide quantitative volumetric
data and to calculate the surface area of each cast.
Metabolite analysis
Plasma samples were analyzed for glucose, nonesterified fatty
acids (NEFAs), triglycerides, albumin, total protein, urea,
lactate and 	-hydroxybutyrate using a Randox Rx Imola
autoanalyser (Randox Laboratories, Crumlin, UK), as de-
scribed previously (48). The osmolality of maternal and
amniotic samples was determined using a cryoscopic osmom-
eter (Osmomat 030; Gonotec, Berlin, Germany). The system
was calibrated against deionized H2O (0 Osmol) and a
standard osmolar solution (300 mOsmol/kg H2O; Gonotec).
Analysis of amino acids in biofluids, after derivatization, was
according to the manufacturer’s instructions (EZ:faast Amino
Acid Kit; Phenomenex, Macclesfield, UK) and as described
previously (48). Amino acid standards were prepared using
the same method and were run every 15 samples to check for
consistency.
Analysis of fetal liver polyamines
Polyamines were determined based on the method of Ekeg-
ren & Gomes-Trolin (49). In brief, a 200 mg sample of fetal
liver was homogenized on ice in HPLC-grade H2O, and an
aliquot was used for determining the protein content (Bio-
Rad DC kit). An internal standard (20 l of 60 M 1,6-DAH)
was added to the homogenate (700 g protein), and the
sample was deproteinized using 4 M perchloric acid. The
supernatant was adjusted to pH 9.0 using 4 M KOH and
derivatized using 0.2 M borate buffer (pH 9.0) and 0.01 M
FMOC reagent (in acetone). The reaction was stopped using
240 l 0.04 M glycine. Twenty microliters of 10
 diluted
sample was injected into a Agilent 1000 HPLC system onto a
Zorbax column C18 (250
4.6 mm ID, 5 m; Agilent Tech-
nologies, Stockport, UK) protected by a 5 m guard column
maintained at 40°C. The fluorescent detector excitation and
emission wavelengths were set at 264 and 310 nm, respec-
tively. Mobile phase A was 0.05 M sodium acetate (pH 4.2),
acetonitrile, 80/20 (v/v), and mobile phase B was 0.05 M
sodium acetate (pH 4.2), acetonitrile, 5/95 (v/v). Unknown
samples were interpolated from a standard curve (0–12 nM)
with a lower limit of detection at 0.1 nM.
Renal immunohistochemistry (IHC)
Renal sections were analyzed for the abundance of vascular
endothelial growth factor A (VEGFA; SC-152; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) using a biotinylated
ABC kit (Vector Laboratories, Peterborough, UK) and cluster
of differentiation factor 34 (CD34; ab81289; Abcam, Cam-
bridge, UK) using a Leica Bond-Max automated system
(Leica Microsystems, Wetzlar, Germany). For VEGFA, the
primary antibody was diluted 1:200 in PBS and 0.05% Tween
and incubated overnight at 4°C. For CD34, the primary
antibody was diluted 1:1000 in Bond Primary Antibody Di-
luent (Leica) and incubated for 30 min at room temperature.
Heat-mediated antigen retrieval was carried out for 10 min
using EDTA (pH 9). Negative controls were included during
each IHC run by omission of primary antibody and using a
rabbit IgG control (Vector Laboratories). For both proteins,
adult ovine kidney was used as a positive control.
Quantitative polymerase chain reaction (qPCR)
Total RNA was extracted using a PureLink Mini Kit (Invitrogen,
Paisley, UK), and cDNA was synthesized using an Omniscript
reverse transcriptase kit (Qiagen, Crawley, UK). Primers were
designed using U.S. National Center for Biotechnology Infor-
mation (NCBI) Primer-BLAST (NCBI, Bethesda, MD, USA;
Table 1) and purchased from Eurofins MWG (Ebersberg,
Germany). qPCR was performed using a Roche SYBR Green
kit (Roche Diagnostics, Burgess Hill, UK) on a Roche Light-
cycler 480 (Roche, Basel, Switzerland). Melt curves were used
to confirm reaction specificity, and cyclophilin, 	-actin, and
GAPDH were used as housekeeping genes. mRNA quantities
were normalized to housekeeping genes using Roche Light-
cycler 480 advanced relative quantification software.
Microarray of fetal kidneys
First, genomic DNA (gDNA) was extracted from whole sheep
blood using the Wizard Genomic DNA Purification kit (Pro-
mega, Southampton, UK) as per manufacturer’s instructions,
then labeled, hybridized to the Affymetrix Human U133  2
array (Affymetrix, Santa Clara, CA, USA), and scanned, and
gDNA cell intensity files (.cel files) were generated. Probe
pairs were identified in which the perfect match (PM) probe
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has a gDNA hybridization intensity greater than the user-
defined threshold and were selected using a .cel file parser
script (http://
affymetrix.arabidopsis.info/xspecies/), which produces a probe
mask file (.cdf) compatible with a range of microarray analysis
packages (e.g., Genespring; Agilent Technologies). Probe
mask files (.cdf) were produced using gDNA hybridization
intensity thresholds ranging from 0 to 1000, as described
previously (50). For microarray of fetal kidneys at 65 d
gestation, n  8 individual male fetuses from each treatment
group (CP and LP) were used, as males were previously
identified as particularly susceptible to maternal LP diet (23),
and restricting the dataset to one sex would reduce hetero-
geneity and improve statistical associations. Total RNA was
isolated from all samples (Trizol; Life Technologies, Grand
Island, NY, USA), and yield and purity were determined prior
to microarray using an Agilent 2100 bioanalyzer. RNA (1 g)
was used to generate first-strand cDNA by reverse transcrip-
tion, followed by synthesis of second-strand cDNA. Double-
stranded cDNA products were purified and in vitro transcribed
to generate biotinylated complementary RNAs (cRNAs). The
cRNAs were purified and randomly fragmented before being
hybridized to the Affymetrix Human U133 2 GeneChip array
and stained with streptavidin-phycoerythrin. Arrays were sca-
nned, and .cel raw data files were generated. The DNA and RNA
.cel files and the probe mask .cdf files are available to down-
load from the NASC Xspecies website (http://affymetrix.
arabidopsis.info/xspecies/).
Bioinformatic analyses of microarray data
Successfully hybridized genes to the X-species microarray
were first normalized using the Li-Wong procedure (51).
Differentially expressed probe sets were then filtered on the
expression level (i.e., 20–100 percentile) to remove back-
ground noise and probes that do not hybridize to the
X-species microarray. The P value was set at 0.05 and fold
change at 1.5-fold to identify probe sets that were significantly
up- or down-regulated between treatment groups. The Data-
base for Annotation, Visualization, and Integrated Discovery
(DAVID) bioinformatics resource (U.S. National Institute of
Allergy and Infectious Diseases, Bethesda, MD, USA; http://
david.abcc.ncifcrf.gov/) was then used to identify gene ontol-
ogies that were overrepresented in the lists of probe sets,
when compared against the list of probe sets expressed above
background levels. All bioinformatic data handling was per-
formed using Genespring GX 7.3 (Agilent Technologies).
Statistical analysis
All data were analyzed using a general linear model for the
fixed effects of diet (e.g., CP vs. LP) or, where appropriate,
the additional effects of sex (male vs. female) or time
(analyzed as a repeated measure within individuals). For
twins, the reduced interindividual variance associated with
being nested within a ewe was analyzed as a general linear
mixed model, with the ewe included as a random effect
(Genstat 15; VSN International, Hemel Hempstead, UK).
The suitability of using a general linear model was assessed by
generating a histogram of residuals and further residual (on
the y axis) plots of fitted values and expected normal quan-
tiles. Skewed plots (residual errors) necessitated log10 trans-
formation before analysis. Data are presented as means with
estimated sem to represent the error between comparisons.
Here 95% confidence intervals may be approximated from
the normally distributed data as the mean  2 se. Correla-
tions between variables were tested using Pearson’s correla-
tion tests. Immunohistochemical data were highly positively
skewed and were analyzed by generalized linear regression
after log10 transformation, fitting a  distribution to residual
errors. Values of P  0.05 were accepted as indicating
statistical significance.
RESULTS
Nutritional status of ewes fed LP diet
Maternal weight and body condition score (BCS) at
artificial insemination (d 0 of gestation) were similar
TABLE 1. Primer details for quantitative PCR
Primer Sequence, 5= to 3= TA (°C)
Angiopoietin 1 F: GGGTCACACTGGGACAGCAGG 58
R: TGGGCCACAGGCATCAAACCA
	-Actin F: TGTGCGTGACATCAAGGAGAA 55
R: CGCAGTGGCCATCTCCTG
CDH11 F: ATCTCCCCCACAGAAATCGC 54
R: CGGCCTCTTCTTCACCCATT
Cyclophilin F: CATACAGGTCCTGGCATCTTGTC 56
R: TGCCATCCAACCACTCAGTCT
GAPDH F: TCCGTTGTGGATCTGACCTG 55
R: TGCTTCACCACCTTCTTGATCTC
THOC1 F: CCATTGAACAGGCAGACCCT 54
R: GGCTTCTCCGTGCTAACAGT
Tie 2 F: CAGCAGACCTCGGAGGCAGGA 58
R: TGCCCTCTTCAGCTGCAGCATG
VEGFA F: GGATGTCTACCAGCGCAGC 56
R: TCTGGGTACTCCTGGAAGATGTC
VEGFR1 F: TGGATTTCAGGTGAGCTTGGA 52
R: TCACCGTGCAAGACAGCTTC
F, forward; R, reverse; TA, annealing temperature; CHD11, cadherin-11; GAPDH, glyceraldehyde
3-phosphate dehydrogenase; THOC1, THO complex subunit 1; VEGFA, vascular endothelial growth
factor A; VEGFR1, vascular endothelial growth factor receptor 1.
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between groups (pooled mean for weight, 56.30.5 kg;
for BCS, 2.50.1 U) and did not deviate significantly
from this level to d 65 (at d65: CP, weight61.21.1 kg,
BCS2.70.1 U; LP, weight58.91.0 kg, BCS
2.50.1 U). From similar initial concentrations in
maternal plasma at d 0, plasma NEFAs, glucose, and
lactate significantly increased, and plasma triglycerides
and albumin showed a strong statistical trend to be
increased, whereas plasma urea significantly decreased
through early gestation in LP relative to CP ewes
(Fig. 1). Despite a 50% reduction in dietary crude
protein, maternal plasma amino acid concentrations did
not differ between treatment groups, although some
variation with time was noted (Table 2). Plasma osmolality
also did not differ between groups at d 0 (pooled mean,
3032 mOsmol/kg H2O) but was, on average, signifi-
cantly increased in LP vs. CP ewes from d 28 onward
(pooled mean, 3234 vs. 3034 mOsmol/kg H2O, re-
spectively; P0.001).
Nutritional status of fetuses exposed to a maternal
LP diet
At d 65, neither maternal diet nor fetal sex had any
effect on measures of fetal growth (weight and crown-
rump length) or on the relative size of fetal organs
(Table 3). Accordingly, measurements of the major
fetal substrates for growth (glucose, lactate, amino
acids) were unaltered by maternal diet or fetal sex, and
hence sexes are combined (fetal plasma glucose,
0.740.09 vs. 0.840.08 mM; fetal plasma lactate, 4.52
0.21 vs. 5.140.18 mM; total amino acids, 3900177 vs.
3643177 M for CP vs. LP, respectively). However,
type rather than quantity of micronutrients was subtly
altered by maternal diet; for example, fetal plasma
glycine was increased by a maternal LP diet (Table 4),
an effect most apparent in female fetuses (CP male,
45034 vs. LP male 45531 M; CP female, 34931
vs. LP female 49932 M), whereas the concentrations
Figure 1. Ewes fed LP diet have reduced plasma
urea, but other biomarkers of nutritional status
are increased. Glucose (A), lactate (A), NEFA
(C), triglyceride (D), total protein (E), albumin
(F), 	-hydroxybutyrate (G), and urea (H) sam-
ples were obtained prior to pregnancy (d 0=)
and at d 28 and 65 of gestation and were
analyzed on a Randox Rx-Imola bioanalyzer.
Data are means  estimated sem for ewes fed a
CP diet (n15; open symbols) or an LP diet
(n16; solid symbols) during early gestation (d
0–65, term 145 d). Data were analyzed by the
general linear model for the fixed effect of diet,
with time included as a repeated measure, and
the interaction term (diet
time) using Genstat
15. NS, nonsignificant; NEFA, nonesterified
fatty acid. aP 0.05 vs. d 0. bP 0.05 vs. control
group.
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of proline and asparagine were significantly lower in
the plasma of female vs. male fetuses, regardless of diet
(Table 4). As expected from maternal nutritional sta-
tus, urea concentration in the amniotic fluid was signif-
icantly reduced in LP vs. CP fetuses (3497339 vs.
6916351 M; P0.001). Due to complex, dependent
interrelationships between amino acids in the fetal
compartment, we used a multivariate statistical ap-
proach to reveal potential treatment effects: linear dis-
criminant analysis of normalized (z scores) standard and
nonstandard (e.g., ornithine) amino acids indicated a
significant separation due to maternal diet (Fig. 2F),
largely contributed by the significant reduction in
ornithine in LP relative to CP fetuses (Fig. 2A, B).
Further analysis of fetal hepatic polyamine concentra-
tions (the major site for polyamine synthesis in the
fetus) indicated a significant reduction in fetal liver
spermine, but not putrescine or spermidine, in LP
relative to CP fetuses (Fig. 2C–E).
Fetal kidney transcriptome and macro- and
microvascular development after exposure to a
maternal LP diet
The macrovascular structure of the fetal kidneys was
directly assessed using vascular corrosion casting, which
produced a detailed 3D representation of the major
vessels in the fetal kidneys at 65 d gestation (Fig. 3A).
Micro-computed tomography (micro-CT) of corrosion
casts indicated no effect of maternal diet nor fetal sex
on cast volume (pooled sexes, Fig. 3B) or surface area
(882156 vs. 1069135 mm2 for control vs. low pro-
tein, respectively; P0.40), but each was highly corre-
lated (R20.97; P0.001). In contrast, the microvascu-
lar density of the fetal kidneys (assessed indirectly by
IHC staining of CD34 and VEGFA) was significantly
blunted in LP-exposed vs. CP fetuses (CD34, Fig. 4;
VEGFA, Fig. 5), particularly in the nephrogenic zone of
the kidney. Analysis at the transcript level (qPCR)
complemented the protein data with respect to blunted
TABLE 2. Standard amino acid concentrations in plasma of ewes fed CP or LP diet to d 65 (0.44 gestation)
Amino acid
Diet Time (d gestation) P
CP LP 0 28 65 D T D 
 T
Alanine 344  28.1 388  28.6 378  33.5 432  36.1 288  34.6 NS 0.05 NS
Glycine 789  73.7 901  77.8 696  86.7 933  98.5 906  92.9 NS NS NS
Isoleucine 94.7  5.54 88.6  6.06 117  6.60 88.5  7.75 69.1  6.94 NS 0.001 NS
Leucine 126  6.90 109  7.00 145  8.20 114  8.80 92.0  8.50 NS 0.001 NS
Valine 416  26.5 382  28.3 530  31.5 380  35.8 286  33.1 NS 0.001 NS
Threonine 53.2  8.41 63.6  9.88 76.0  9.98 62.0  12.3 37.2  11.3 NS NS NS
Proline 72.9  4.29 68.5  4.82 84.5  5.11 74.8  6.26 52.5  5.32 NS 0.001 NS
Phenylalanine 69.3  4.75 59.1  5.19 77.5  5.75 61.2  6.64 54.0  5.85 NS 0.05 NS
Tryptophan 50.4  9.17 60.3  10.8 70.9  12.4 63.5  12.7 31.7  11.7 NS NS NS
Tyrosine 49.4  4.87 41.4  5.29 66.7  6.02 40.8  6.64 28.3  6.02 NS 0.001 NS
Lysine 181  39.1 225  47.3 213  45.9 265  55.4 131  57.5 NS NS NS
Asparagine 27.8  2.52 23.8  2.83 34.9  3.10 26.4  3.47 16.3  3.25 NS 0.001 NS
Aspartic acid 6.73  1.39 6.50  1.56 5.61  1.81 5.20  1.89 9.05  1.73 NS NS NS
Glutamic acid 109  14.4 82.3  15.4 96.4  16.0 141  17.6 49.2  20.7 NS 0.001 NS
Total 2306  210 2600  237 2610  245 2861  279 1889  296 NS NS NS
Data are mean sem concentrations (M) for ewes fed a CP (n15) or LP (n16) diet to d 65 gestation. Data were analyzed by the general
linear model for the fixed effects of diet (D), time (T), or their interaction (D
T) using Genstat 14. NS, nonsignificant. Values of P 0.05 were
considered significant.
TABLE 3. Fetal body and organ weight at d 65 (0.44 gestation) from ewes fed control or low protein diet
Parameter
Male fetuses Female fetuses P
CP LP CP LP D S D 
 S
n 7 8 8 8
Fetal weight (g) 126  8 123  8 131  9 120  8 0.42 0.90 0.68
Crown-rump length (cm) 16.6  0.4 17.4  0.4 17.3  0.4 16.7  0.4 0.74 0.88 0.09
Heart weight (g/100 g) 0.95  0.03 0.91  0.03 0.85  0.03 0.97  0.03 0.39 0.56 0.02
Kidney weight (g/100 g) 1.42  0.05 1.42  0.05 1.28  0.06 1.44  0.05 0.23 0.33 0.22
Liver weight (g/100 g) 6.90  0.19 6.61  0.21 6.64  0.22 6.86  0.19 0.85 0.97 0.23
Data are means  sem for ewes bearing twins fed a CP diet (n15 ewes, n30 fetuses) or an LP diet (n16 ewes, n32 fetuses) to d 65
or 0.44 gestation. Data were analyzed by the general linear mixed model for the fixed effects of diet (D; CP vs. LP) or fetal sex (S; male or
female). Ewe was incorporated as a random effect in the model due to the nested, reduced variability of twins sharing the same intrauterine
environment. All analyses were conducted using Genstat 14, and statistical significance was considered acceptable at P  0.05; effects on fetal
organs were considered only after correction for fetal body size. Maternal weights at postmortem did not differ between diet groups (CP,
60.51.0 vs. LP, 58.41.0 kg; P0.15).
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microvascular developmental potential in the kidney of
LP-exposed fetuses (Table 5).
Transcriptomics of the d 65 (0.44 gestation) fetal
kidney identified a total of 9218 genes with known
accession numbers that successfully hybridized to the
X-species microarray. From this background list, after a
strict data normalization and filtering process, a total of
52 genes were significantly (P0.05, fold change1.5)
up-regulated and 31 significantly down-regulated (Ta-
bles S1 and S2, respectively) in LP vs. CP fetuses. The
pathways that were significantly overrepresented (i.e.,
10% known genes in each pathway) within each up- or
down-regulated gene list are given in Table S3; of interest,
the majority of pathways to which the up-regulated genes
in LP-exposed fetal kidneys corresponded were con-
cerned with negative regulation of cellular processes (i.e.,
inhibition of cellular growth), and notable genes of
interest were Bcl-2-associated transcription factor 1
(BCLAF1), S-methyl-5=-thioadenosine phosphorylase,
and DNA (cytosine-5)-methyltransferase 3A. The major-
ity of pathways that the down-regulated genes in low
protein exposed fetal kidneys associated with were
positive regulation of biosynthetic processes and cell
adhesion, with notable genes of interest being eukary-
otic translation initiation factor 5A (EIF5A) and cad-
herin-11 (CDH11). Using qPCR to validate selected
microarray results, we confirmed down-regulated ex-
pression of THOC1 and CDH11 in LP relative to CP
fetuses. Taken together, the fetal kidney microarray
data indicated that there is considerable endogenous
variation in gene expression between individuals in the
same nutritional group, but a maternal LP diet specif-
ically affects the fetal kidney transcriptome at 0.44 d
gestation, with the net balance of gene expression in
biosynthetic pathways suggesting reduced intracellular
availability of metabolic substrate for renal cell devel-
opment, reduced cell-cell adhesion, and increased ap-
optosis.
DISCUSSION
We previously observed maternal PEM during early ges-
tation to specifically affect development of the fetal kidney
to reveal an adult phenotype with fewer nephrons, micro-
vascular rarefaction, and blunted kidney function (23).
We interpreted these effects as potentially underpinning
the relationship between PEM, low birth weight, and
adult (particularly renal) health or disease (52). How-
ever, due to a lack of available biofluids, we were unable
to directly attribute our fetal and subsequent adult
phenotype to any specific change in the pattern of
nutrients in either the maternal or fetal compartments.
Here we repeated our PEM paradigm using a larger
cohort of serial sampled ewes to generate sufficient
numbers of male and female twin fetuses, spot-sampled
at d 65 (0.44 gestation). We hypothesized that maternal
PEM diminishes availability of fetal macro- and micro-
nutrients to compromise development of the fetal
kidney vasculature, effects that underpin nutritional
programming of kidney development. Combining our
established ovine model of PEM with state-of-the-art
transcriptomic analyses, we “phenocopied” and ex-
tended our previous data of blunted developmental
potential, particularly microvascular, in the fetal kid-
ney. We now extend these data to show, for the first
time, that this effect is most probably mediated via
diminished activity of the ornithine cycle, reducing
availability of substrate for polyamine biosynthesis to
fuel microvascular cell development. Equally, we rule
out any effects of maternal or fetal macronutrient
balance on fetal kidney macrovascular development.
TABLE 4. Standard measureable amino acid concentrations (M) in fetal plasma at 65 d (0.44 gestation)
Amino acid
Diet Sex P
CP LP M F D S D 
 S
Alanine 285  14.5 266  14.5 280  14.7 272  14.2 NS NS NS
Glycine 397  22.8 479  26.2 454  24.3 426  24.3 0.01 NS 0.03a
Isoleucine 78.9  4.44 76.1  4.11 82.8  4.48 72.5  4.33 NS NS NS
Leucine 140  6.06 127  5.93 141  6.06 126  5.96 NS NS NS
Valine 212  12.3 199  11.3 216  12.3 196  11.7 NS NS NS
Serine 700  49.1 691  48.1 678  47.3 717  50.0 NS NS NS
Threonine 448  35.3 463  32.9 498  34.6 417  33.5 NS NS NS
Proline 119  5.99 116  5.57 127  5.99 109  5.79 NS 0.05 NS
Phenylalanine 175  8.97 174  8.75 187  9.14 163  8.99 NS NS NS
Tryptophan 87.2  12.7 88.6  12.7 92.0  11.3 84.0  11.0 NS NS NS
Tyrosine 277  27.7 231  22.9 269  23.1 241  22.4 NS NS NS
Lysine 702  65.1 540  61.8 662  63.9 574  62.8 NS NS NS
Asparagine 54.6  2.87 54.1  2.73 59.6  2.77 49.4  2.77 NS 0.05 NS
Aspartic acid 9.66  0.66 9.16  0.60 10.4  0.66 8.41  0.66 NS NS NS
Glutamic acid 218  16.8 224  15.9 233  16.3 209  16.5 NS NS NS
Total 3821  179 3580  170 3832  174 3557  174 NS NS NS
Data are mean  sem concentrations (M) for fetuses of ewes fed a CP diet (n29: males, n13; females, n16) or an LP diet (n31:
males, n16; females, n15) to d 65 gestation. Data were analyzed by the general linear mixed model for the fixed effects of diet (D), sex (S),
or their interaction (D
S) using Genstat 14. The ewe was included as a random term in the model. NS, nonsignificant. Values of P  0.05 were
considered significant. aData illustrating the statistically significant interaction are in the Results section.
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We also failed to observe any sex-specific response to
maternal PEM. As a consequence of maternal PEM,
defective fetal amino acid/polyamine metabolism most
probably underpins programming of fetal kidney devel-
opment and subsequent function.
First, and notably, we confirm our previous observa-
tions on the effect of PEM on the fetal kidney: reduced
transcript expression and protein abundance of the key
drivers of angiogenesis (VEGFA, VEGFR1, Ang1, and
Tie 2; Table 4 and Fig. 5), were evident, together with
reduced abundance of CD34 cells (an endothelial cell
marker, Fig. 4). These effects were greatest in the
nephrogenic zone (for angiogenic factors) and peritu-
bular capillaries and mature glomeruli (for CD34, as
observed in human fetal kidneys) (53). Similar effects
in the fetal pancreas (reduced VEGFA and microvascu-
lar density, increased apoptosis) have been observed
previously after maternal PEM in a rat model (54, 55).
Hence, we suggest that a common response to maternal
PEM is reduced developmental potential of organs
(our focus is the kidney) through a reduction of factors
that support cell growth (e.g., angiogenesis, vasculogen-
esis) and an increase in factors that inhibit growth (e.g.,
apoptosis). An unbiased global transcriptomic overview
of differences in fetal kidney gene expression between
control and PEM supports this view (Supplemental
Tables S1–S3). The question arises as to what extent
reduced microvascular development, in part engen-
dered by inadequate organ perfusion, i.e., reduced
regional macrovascular development, can physically
restrict nutrient supply to developing organs.
To address this question, we generated a macrovas-
cular corrosion cast of the fetal kidneys at d 65 gesta-
tion (Supplemental Movie S1 and Fig. 3) and quanti-
fied the cast volumetrically by micro-CT. Batson’s
methylmethacrylate, as used here, is the preferred resin
for such studies (56), but using this technique, we
observed no effect of PEM on intrarenal macrovascular
structure or density between treatment groups. We
therefore infer from these data that the ability to supply
the kidneys with sufficient blood to support growth is
not compromised by maternal PEM. Hence, when
taken together with reduced microvascular density
(Fig. 4), we can infer that maternal PEM has an effect
on the fetal kidney at a cellular level (e.g., endothe-
lium) to either reduce the ability to functionally enable
growth (e.g., by transfer of sufficient substrate) or
physically support growth (e.g., reduced cell adhesion).
Figure 2. Maternal LP diet reduces the availability of ornithine in the fetal compartment and hepatic spermine concentration.
A, B) Ornithine was measured in fetal plasma (A) and amniotic fluid (B) using gas chromatography-mass spectrometry (see
Materials and Methods). C–E) The polyamines putrescine (C), spermidine (D), and spermine (E) were measured in lysates of
fetal liver using high-performance liquid chromatography. Data are dot plots of data points from individual fetuses (A–E) with
the line indicating the mean from each dietary treatment. Data were analyzed by the general linear mixed model for the fixed
effects of diet, sex, and their interaction (ewe included as a random effect in the model) using Genstat 15. F) Linear
discriminant plot generated after multivariate analysis of 18 amino acids in fetal plasma (circles representing 95% confidence
interval around group means) conducted after normalization of data (by establishing z scores). NS, nonsignificant. Values of P
0.05 were considered significant.
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It should be noted, however, that using the corrosion
casting technique has some drawbacks: while we in-
fused sufficient resin (7 ml) in a retrograde fashion into
the umbilical artery to perfuse the intact fetal body and
observe reverse perfusion of the umbilical vein, we
could not witness perfusion of the fetal kidneys. Thus,
while vascular corrosion casting with micro-CT quanti-
fication has been used previously to image individual
renal corpuscles in adult animals (57), but not to our
knowledge in fetuses, our macrovascular data may have
underestimated the true vascularity of the kidney. Nev-
ertheless, we now provide robust evidence that mater-
nal PEM has a significant effect on the developing fetal
kidney at a cellular level, effects that can lead to an
anatomically and physiologically compromised mature
adult kidney. This then raises the question as to the
extent by which these subtle effects of maternal PEM in
the fetal kidney associate with specific changes to fetal
macro- and micronutrient balance. Indeed, can we
infer that fetal PEM is a consistent response to maternal
PEM?
For the first 65 d of pregnancy in sheep, ca. 50%
protein restriction had few obvious effects on the
mother, such as reduced weight gain, or on the levels
of intermediary metabolites in her circulation. Sig-
nificantly reduced plasma urea was noted, but levels
remained within published reference ranges for
sheep (58, 59). Essentially, the dietary regimen was
asymptomatic vis-a`-vis maternal weight gain, body
composition and plasma chemistry. Serial sampling,
however, revealed a trend with time in the LP-fed
ewes from which we may speculate a metabolic effect,
an increased reliance on lipolysis for energy; and a
physiological effect, a reduced renal ability to con-
centrate urine and, hence, greater free water clear-
ance. The latter effect is inferred by a concomitant
early increase (cf. control ewes) in glucose, lactate,
total protein, and albumin together with an increase
in plasma osmolality. In rats, PEM reduced plasma
volume expansion (60). Feeding of an LP diet is
known to reduce plasma urea (61, 62), which can
have a diuretic effect as the renal medullary intersti-
tial gradient for fluid reabsorption is reduced (63).
Urea is a very small molecule that can readily cross
the placenta (64). The urea/ornithine cycle is an
important metabolic pathway generating valuable
intermediary metabolites for the growing fetus. We
therefore asked whether these maternal effects of an
LP diet had significance for the fetus, primarily in
terms of the growth and development of the kidney.
For most macro- and micronutrients, the relation-
ship between maternal and fetal compartments is not
linear, because the placenta considerably consumes
or produces substrate to protect the fetal nutritional
milieu (65). Placentation in sheep begins around d
28 and is established by d 65 (66). Previous studies
have illustrated that maternal nutrient deprivation
can affect the fetal nutritional environment, but
considerable study-to-study variability exists, and a
consistent response has not emerged (29 –32, 34).
Here we show in a large group of fetuses of both
sexes that at around 0.40 gestation in the sheep,
maternal PEM has little effect on fetal macronutrient
status. There was no difference in fetal plasma glu-
cose, lactate, or total amino acid (Table 3) concen-
trations: the primary sources of energy for fetal
oxidative metabolism and growth (67, 68). Conse-
quently, growth of the fetus to this stage (whether a
male or female) was also unaffected by maternal diet.
However, notably, closer statistical examination us-
ing multivariate discriminant analysis of the stan-
dardized variation in measureable amino acids re-
veals a consistent pattern in male and female LP-
exposed vs. CP fetuses (Fig. 2F) that can be largely
explained by the change in only a few amino acids
and their intermediary metabolites. Our principal
Figure 3. Fetal kidney macrovasculature is unaffected by
maternal LP diet. A) Representative vascular corrosion cast of
a fetal kidney generated using Batson’s No. 17 Plastic Replica
and Corrosion Kit. Volume and surface area of resin casts was
quantified using a Nanotom high-resolution micro-CT scan-
ner. B) Dot plot of quantified volumetric data from casts, line
at predicted mean for each group. Data are for ewes fed a CP
diet (control fetuses: male, n8; female, n7) or LP diet
from d 0 to 65 of gestation (LP-exposed fetuses: male, n8;
female, n8). Data were analyzed by the general linear mixed
model for the fixed effects of diet, sex, and their interaction
term (diet
sex) using Genstat 15. Supplemental Movie S1
illustrates 3D volumetric acquisition of vascular corrosion cast
data. NS, nonsignificant. Values of P  0.05 were considered
significant.
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observations (i.e., the variates with the largest dis-
criminant scores), which were consistent in both fetal
plasma and amniotic fluids, was that urea and orni-
thine were significantly reduced and glycine signifi-
cantly increased in LP vs. CP fetuses. Similar effects,
albeit in different nutritional paradigms, have been
observed previously in sheep (29, 33) and nonhuman
primates (34).
The ability of maternal PEM to specifically affect fetal
urea/ornithine and glycine metabolism is of interest,
particularly with regard to reduced developmental po-
tential in the fetal kidney. Ornithine is the primary
precursor for the synthesis of the polyamines pu-
trescine, spermidine, and spermine (69). Polyamines
have diverse biological roles in the cell but primarily
fuel proliferation and differentiation (70), and when
they are depleted in mammalian cells, growth ceases
(71). In the livers of fetuses exposed to maternal
PEM, we detected significantly less spermine (Fig.
2E). The liver is the primary site for polyamine
synthesis in the fetus and is a better index of fetal
polyamine status, as opposed to values in fetal plasma
or amniotic fluid (29). Indeed, in our hands, poly-
amines were undetectable in amniotic fluid (assay
sensitivity of 0.1 nM). Interestingly, our unbiased
transcriptomic screen identified a significant down-
regulation of eukaryotic initiation factor 5A (EIF5a),
a gene essential for translation-elongation and hence
protein synthesis (72). EIF5A is the only known
protein to contain hypusine, a nonclassical amino
acid formed from spermidine (73). Moreover, gly-
cine and serine are readily interconvertible, but
serine to glycine is favored in highly proliferative
cells (such as a developing fetus) due to the net
Figure 4. Fetal kidney microvasculature (density of endothelial cells; CD34) is blunted by maternal low protein diet. Fetal kidney
microvasculature was indirectly determined using immunohistochemistry and quantification of cells positive for CD34. A)
Representative micrograph of the nephrogenic zone, CD34 staining is brown, black arrows indicate peritubular capillaries, white
arrows show staining of glomerular capillaries. B) Dot plot of individual data points for control and LP-exposed fetuses (control:
male, n8; females n7; LP diet: male, n8; female, n8). C) Positive control, adult ovine kidney. D, E) Negative controls,
omission of primary antibody (D) and rabbit IgG (E). All images are 
200. Data were analyzed by the general linear mixed
model for the fixed effects of diet, sex, and their interaction term (diet
sex) using Genstat 15. NS, nonsignificant. Values of
P  0.05 were considered significant.
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formation of 5-methyltetrahydrofolate (5-meTHF),
which is used to support a number of cellular reac-
tions, including nucleotide synthesis and DNA meth-
ylation. Increased glycine concentration, as observed
in our study in the fetal compartment, through either
increased dietary supply or blockade of the glycine
cleavage system, can deplete 5-meTHF and inhibit
proliferation of endothelial cells (74), an effect
witnessed in this and previous studies by us (23), in
the kidneys of PEM fetuses (less CD34 staining). In
addition, decreased cellular polyamines can influ-
ence the ability of cells to participate in DNA meth-
ylation reactions (75). This raises the possibility that
maternal PEM may act, via a blunting of the fetal
ornithine cycle and concomitant knock-on effects on
cellular polyamine metabolism, to alter the epige-
netic status of developmentally important genes. A
consequence, as witnessed here, is altered organ
development that persists and manifests as longer-
term organ dysfunction (15, 23).
In summary, we illustrate how mild, maternal PEM
experienced during early gestation can significantly
restrict the developmental potential of the fetal kidney
and highlight a nutritional pathway that may underpin
this effect. Maternal PEM reduces maternal and fetal
urea concentrations to constrain the fetal ornithine
cycle and reduce availability of substrates (e.g., poly-
amines) for cell proliferation. Increased glycine in the
fetal compartment may also represent depleted micro-
nutrient availability (e.g., 5-meTHF) that exacerbates
the balance of nutrients to favor cellular arrest rather
than growth.
The authors acknowledge Dr. Jim Craigon for statistical
advice on the manuscript. L.J.D. was supported by a British
Heart Foundation Ph.D. studentship (FS/09/011/26562)
and a Society for Endocrinology Early Career grant. The
experiments were conducted at the School of Veterinary
Medicine and Science (Sutton Bonington Campus, University
of Nottingham, Loughborough, UK). D.S.G., L.J.D., and
K.D.S conceived and designed the experiments; L.J.D.,
Figure 5. Fetal kidney angiogenic potential,
measured as VEGFA, is blunted by maternal LP
diet. Fetal kidney angiogenic potential was in-
directly determined using immunohistochemis-
try and quantification of cells positive for
VEGFA. A) Representative micrograph of the
nephrogenic zone: VEGFA staining is brown;
white arrows indicate developing collecting
ducts. B) Dot plot of individual data points for
control and LP-exposed fetuses (control: male,
n8; females n7; LP diet: male, n8; female,
n8). C) Positive control, mouse kidney. D, E)
Negative controls, omission of primary anti-
body (D) and rabbit IgG isotype control (E). All
micrographs were taken at 
200. Data were
analyzed by the general linear mixed model for
the fixed effects of diet, sex, and their interac-
tion term (diet
sex) using Genstat 15. NS,
nonsignificant. Values of P  0.05 were consid-
ered significant.
TABLE 5. Blunted angiogenic potential in the kidney of fetuses exposed to maternal LP diet, as revealed by transcript expression of
angiogenic factors
Gene
Diet Sex P
CP LP M F D S D 
 S
Angiopoietin 13.7  0.79 11.5  0.74 13.1  0.74 11.9  0.79 0.062 NS NS
Tie 2 1.52  0.08 1.32  0.07 1.40  0.07 1.42  0.08 0.065 NS NS
VEGFA 13.7  0.63 11.4  0.59 12.8  0.59 12.0  0.63 0.014 NS NS
VEGFR1 16.7  0.99 13.7  0.92 14.4  0.92 15.6  0.99 0.036 NS NS
Data are mean  sem units 
 102 for fetuses from ewes fed a CP diet (n15) or an LP diet n16) to d 65 gestation. Data were analyzed
by the general linear mixed model for the fixed effects of diet (D), sex (S), or their interaction (D
S) using Genstat 14. NS, nonsignificant.
Values of P  0.05 were considered significant.
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